Drug Metabolism Letters
Volume 14, 3 Issues, 2020
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Drug Metabolism Letters, Volume 9 - Number 2
Editorial
Alterations in Hepatic Lipid Metabolism, and their Relation to Dietary Macronutrients in Pediatric Nonalcoholic Fatty Liver Disease
, 9(2): 72 - 79David E. St-Jules and Corilee A. Watters
DOI: 10.2174/1872312809666150907115208
Predicting Pediatric Drug Disposition-Present and Future Directions of Pediatric Physiologically-Based Pharmacokinetics
, 9(2): 80 - 87Shogo John Miyagi and Janel R. Long-Boyle
DOI: 10.2174/1872312809666150602151429
The Effects of Obesity on Drug Metabolism in Children
, 9(2): 88 - 98Steffen G. Oeser, Luc R.A. Rougee and Abby C. Collier
DOI: 10.2174/1872312809666150804111612
Downregulation of Hepatic Carbonyl Reductase Type 1 in End-Stage Renal Disease
, 9(2): 111 - 118Osama Y. Alshogran, Bradley L. Urquhart and Thomas D. Nolin
DOI: 10.2174/1872312809666150818111626
Non-Clinical Disposition and Metabolism of DM1, a Component of Trastuzumab Emtansine (T-DM1), in Sprague Dawley Rats
, 9(2): 119 - 131Ben-Quan Shen, Daniela Bumbaca, Qin Yue, Ola Saad, Jay Tibbitts, S. Cyrus Khojasteh and Sandhya Girish
DOI: 10.2174/1872312809666150602151922
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared
, 9(2): 132 - 137Martina Fabris, Cinzia Pistis, Alen Zabotti, Luca Picco, Francesco Curcio, Elio Tonutti and Salvatore De Vita
DOI: 10.2174/1872312809666150807104717
Editor-in-Chief
Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)
Biography
Alliance Pharma
Malvern, PA
Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serve as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.01
Advertisement
Webmaster Contact: info@benthamscience.net